News & Events

Filter By:
14 October
2021
Inspira Technologies to Present In-Person at the HLTH Conference in Boston
Read More
30 September
2021
Inspira Technologies to Host COVID-19 Virtual Conference on October 6
Read More
22 September
2021
Inspira Technologies’ “Artificial Lung” to Acquire a Digital Edge: The Company Contracted GlobalLogic, a Hitachi Group Company, for Advanced Digital Product Engineering Services
Read More
22 September
2021
Inspira Technologies’ “Artificial Lung” To Acquire A Digital Edge: The Company Contracted GlobalLogic, A Hitachi Group Company, For Advanced Digital Product Engineering Services
Read More
15 September
2021
Inspira Technologies Files a Patent Application for a Supportive Device to be Utilized with the ART Device
Read More
12 September
2021
Listen To Joe Hayon, Inspira-Technologies’ President, CFO & Co-Founder, Sharing Inspira’s Sharing The Company’s Go-To-Market Strategy
Read More
09 September
2021
Inspira Technologies to Participate in Upcoming Conferences in September
Read More
13 August
2021
Inspira Technologies Announces First Half 2021 Financial Results and Provides Business Update
Read More
10 August
2021
Inspira Technologies Expands Board of Directors to Accelerate Company’s Go-to-Market Efforts
Read More
10 August
2021
Low Flow Extracorporeal Oxygenation Approach Is The Future Of Acute Respiratory Care
Read More
06 August
2021
An Interview With Dagi Ben-Noon, CEO At Inspira Technologies
Read More
05 August
2021
Top 115 Medical And Healthcare Startups In Israel
Read More
02 August
2021
EXCLUSIVE: Inspira Aims To Replace Mechanical Ventilation With Augmented Respiratory Technology
Read More
26 July
2021
Inspira Expands Medical Advisory Board as Part of Future Expansion into North American Market
Read More
22 July
2021
10+ Best Healthcare Startups: Inspiration And Brave Findings Nearby
Read More
19 July
2021
Inspira Technologies and Ben-Gurion University Have Developed a Platform Designed to Prevent Blood Clotting in Inspira’s ART System
Read More
16 July
2021
Inspira Technologies Reached Important Milestone as It Completed a Pump Bench Study
Read More
16 July
2021
Inspira Technologies OXY B.H.N. Ltd Announces Closing of Initial Public Offering
Read More
13 July
2021
Inspira Technologies OXY B.H.N. Ltd Announces Pricing of Initial Public Offering
Read More
28 June
2021
The Future Of Respiratory By Inspira Technologies: Breathing Without Lungs
Read More
16 June
2021
INSPIRA-Technologies Announces New Medical Advisory Board Member – Dr. Avraham Abutbul – Specialist in Internal Medicine, General Intensive Care Medicine and Pulmonary Medicine
Read More
20 May
2021
Inspira’s Proprietary Augmented Respiration Technology (ART)
Read More
14 April
2021
Q&A: An Intelligent Oxygenation System That Could Eliminate Need For Ventilators
Read More
31 March
2021
This IPO Stock Resembles Nanox, Is Inspira IINN Stock A Buy
Read More
29 March
2021
Breakthrough Oxygenation | Professor Benad Goldwasser
Read More
18 March
2021
Hillel’s Tech Corner: Inspira Makes Breathing Easy
Read More
04 March
2021
Inspira Technologies
Read More
24 February
2021
Inspira Technologies Appoints Benad Goldwasser As Chairman Of The Board
Read More
17 February
2021
Inspira Technologies and Sheba Medical Center Collaborate on Breakthrough Respiration Treatment
Read More
17 February
2021
Sheba And Inspira Technologies Implement Respiratory Treatment For Covid-19 Patients
Read More
10 December
2020
Inspira Technologies Reveals the AXT – An Intelligent System that Directly Oxygenates Blood for Respiratory Care
Read More
03 December
2020
Inspira Technologies Files U.S. Patent Application for its Innovative Respiratory Support Technology; Engages Leading U.S. Investment Bank for NASDAQ Listing
Read More

Get in Touch!

    Ha-Tidhar St 2, Ra'anana, Israel

    I consent to receive emails from Inspira Technologies Oxy B.H.N LTD. To request removal from the mailing list at any time, please send an email to info@inspirao2.com. You can find out about your rights and privacy choices, and how we use your information in our Privacy Policy.